(SeaPRwire) –
By: Ethan Gallagher
Last week, I sat in a Silicon Valley medtech board meeting. The founders were frantic. Their custom biopsy needle supplier missed a FDA validation window. Most off-the-shelf parts don’t fit their novel tool. Too many OEMs cut corners on precision to hit volume targets.
Shanghai Mekon Medical Devices was founded in 2009. It’s a leading custom needle OEM based in China. The firm runs a full end-to-end production line. This includes tube welding, machining, cleaning and sterilization. It holds CE, ISO 13485, FDA 510(k), MDSAP and TGA certifications. It serves customers across six global regions.
The medtech industry has long struggled with fragmented component suppliers. Most firms outsource single steps, leading to quality gaps and delays. Mekon’s integrated model fixes this. It takes customer drawings or samples, offers design support and rapid prototyping. It makes hundreds of custom products yearly, from anesthesia needles to insulin pump accessories. Global demand for specialized needles has surged as minimally invasive procedures grow.
Global medtech makers will shift to fully integrated custom component partners like Mekon in the next 18 months.
Author bio: Ethan Gallagher, a Silicon Valley Hardware Architect and Infrastructure Strategist focused on medical device manufacturing and global supply chains.